JPWO2023056295A5 - - Google Patents
Info
- Publication number
- JPWO2023056295A5 JPWO2023056295A5 JP2024519586A JP2024519586A JPWO2023056295A5 JP WO2023056295 A5 JPWO2023056295 A5 JP WO2023056295A5 JP 2024519586 A JP2024519586 A JP 2024519586A JP 2024519586 A JP2024519586 A JP 2024519586A JP WO2023056295 A5 JPWO2023056295 A5 JP WO2023056295A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- position corresponding
- uracil
- guanine
- complement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163250492P | 2021-09-30 | 2021-09-30 | |
| US63/250,492 | 2021-09-30 | ||
| PCT/US2022/077176 WO2023056295A1 (en) | 2021-09-30 | 2022-09-28 | Treatment of glaucoma with rho guanine nucleotide exchange factor 12 (arhgef12) inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024535110A JP2024535110A (ja) | 2024-09-26 |
| JP2024535110A5 JP2024535110A5 (https=) | 2025-09-30 |
| JPWO2023056295A5 true JPWO2023056295A5 (https=) | 2025-09-30 |
Family
ID=83996920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024519586A Pending JP2024535110A (ja) | 2021-09-30 | 2022-09-28 | Ｒｈｏグアニンヌクレオチド交換因子１２（ＡＲＨＧＥＦ１２）阻害剤による緑内障の治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12577562B2 (https=) |
| EP (1) | EP4408535A1 (https=) |
| JP (1) | JP2024535110A (https=) |
| KR (1) | KR20240099232A9 (https=) |
| CN (1) | CN118891050A (https=) |
| AU (1) | AU2022357497A1 (https=) |
| CA (1) | CA3232251A1 (https=) |
| IL (1) | IL311711A (https=) |
| WO (1) | WO2023056295A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7972612B2 (en) | 2002-11-18 | 2011-07-05 | Santen Pharmaceutical Co., Ltd. | Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker |
| US20090264533A1 (en) * | 2005-03-30 | 2009-10-22 | Richard Neubig | Methods and Compositions for Modulating RHO-Mediated Gene Transcription |
| AR057252A1 (es) | 2005-12-27 | 2007-11-21 | Alcon Mfg Ltd | Inhibicion de rho quinasa mediada por arni para el tratamiento de trastornos oculares |
| GB201107176D0 (en) * | 2011-04-28 | 2011-06-15 | Cxr Biosciences Ltd | Pyrrolnitrin derivatives |
| EP3866790A4 (en) | 2018-10-15 | 2022-08-03 | Ocuphire Pharma, Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA AND RELATED DISEASES |
| JP2022523301A (ja) * | 2019-01-23 | 2022-04-22 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | アンジオポエチン様７（ａｎｇｐｔｌ７）阻害剤による眼疾患の治療 |
-
2022
- 2022-09-28 EP EP22797214.8A patent/EP4408535A1/en active Pending
- 2022-09-28 WO PCT/US2022/077176 patent/WO2023056295A1/en not_active Ceased
- 2022-09-28 CN CN202280075189.3A patent/CN118891050A/zh active Pending
- 2022-09-28 KR KR1020247014295A patent/KR20240099232A9/ko active Pending
- 2022-09-28 CA CA3232251A patent/CA3232251A1/en active Pending
- 2022-09-28 US US17/936,244 patent/US12577562B2/en active Active
- 2022-09-28 JP JP2024519586A patent/JP2024535110A/ja active Pending
- 2022-09-28 IL IL311711A patent/IL311711A/en unknown
- 2022-09-28 AU AU2022357497A patent/AU2022357497A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20120322858A1 (en) | Compositions and Methods for Inhibiting Expression of a Mutant Gene | |
| US20090312394A1 (en) | Protection against and treatment of age related macular degeneration | |
| US20240102013A1 (en) | Treatment Of Ophthalmic Conditions With Son of Sevenless 2 (SOS2) Inhibitors | |
| JP7574206B2 (ja) | ステロール調節エレメント結合転写因子１（ｓｒｅｂｆ１）阻害剤による上昇した脂質レベルの治療 | |
| JPWO2020154268A5 (https=) | ||
| JPWO2023056295A5 (https=) | ||
| CN117255694A (zh) | 用磷酸二酯酶3b(pde3b)抑制剂治疗肝病的方法 | |
| JPWO2021262601A5 (https=) | ||
| JPWO2023064850A5 (https=) | ||
| US20250084419A1 (en) | Treatment Of Acne Rosacea With Pancreatic Lipase-Related Protein 3 (PNLIPRP3) Inhibitors | |
| RU2024102379A (ru) | Лечение офтальмологических патологических состояний ингибиторами ангиопоэтин-подобного белка 7 (angptl7) | |
| US20230242988A1 (en) | Methods Of Improving Health With Apolipoprotein E (APOE) Inhibitors | |
| CN118891050A (zh) | 用Rho鸟嘌呤核苷酸交换因子12(ARHGEF12)抑制剂治疗青光眼 | |
| RU2021121850A (ru) | Лечение офтальмологических патологических состояний ингибиторами ангиопоэтин-подобного белка 7 (angptl7) | |
| CN118265529A (zh) | 使用camp应答元件结合蛋白3样3(creb3l3)抑制剂的肝病治疗 | |
| RU2023131494A (ru) | Лечение цереброваскулярного заболевания с помощью агентов - белков-гомологов 3 нейрогенного локуса notch (notch3) | |
| CN121969751A (zh) | 使用补体因子d (cfd)抑制剂治疗黄斑变性 | |
| EP4363583A1 (en) | Methods of treating asthma with solute carrier family 27 member 3 (slc27a3) inhibitors | |
| WO2024158888A1 (en) | Treatment of stroke with 1,4-alpha-glucan-branching enzyme (gbe1) inhibitors | |
| WO2025080823A1 (en) | Treatment of macular degeneration with complement factor d (cfd) inhibitors | |
| WO2025096087A9 (en) | Treatment of myeloid cell dysfunction with membrane spanning 4-domains a6a (ms4a6a) inhibitors | |
| JPWO2023034761A5 (https=) | ||
| JPWO2020191141A5 (https=) | ||
| CN118488844A (zh) | 用淋巴细胞抗原75(ly75)、分化簇164(cd164)或聚(adp-核糖)聚合酶1(parp1)抑制剂治疗不确定潜能的克隆性造血(chip)的方法 | |
| CN117597132A (zh) | 用环指蛋白213(rnf213)抑制剂治疗肝病 |